Back
KraneShares Emerging Markets Consumer Tech Idx ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
58
KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF
Last Price:
$25.25
Seasonality Move:
0.75%
Buy
78
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.21
Seasonality Move:
11.35%
Buy
58
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ)
is a Buy
Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?
-
The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $25.24. The Score for KEMQ is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
KEMQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.35. The Score for CDTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KEMQ Stock Price Chart
What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?
-
The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $25.24The current trend is relatively stagnant and KEMQ is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.35The current trend is moderately bullish and CDTX is experiencing slight buying pressure.
KEMQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 42.24 | Sell |
| Chaikin Money Flow: | -3597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.24 - 26.08) | Sell |
| Bollinger Bands (100): | (23.78 - 26.76) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.79 | Buy |
| Relative Strength Index (14 RSI): | 84.87 | Buy |
| Chaikin Money Flow: | 261741 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (192.91 - 237.53) | Buy |
| Bollinger Bands (100): | (54.69 - 176.45) | Buy |
KEMQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.49 | Sell |
| 20-day SMA: | 25.54 | Sell |
| 50-day SMA: | 26.08 | Sell |
| 200-day SMA: | 22.75 | Buy |
| 8-day EMA: | 25.37 | Sell |
| 20-day EMA: | 25.63 | Sell |
| 50-day EMA: | 25.34 | Sell |
| 200-day EMA: | 16.14 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.19 | Buy |
| 20-day SMA: | 220.08 | Buy |
| 50-day SMA: | 159.67 | Buy |
| 200-day SMA: | 72.77 | Buy |
| 8-day EMA: | 219.95 | Buy |
| 20-day EMA: | 209.45 | Buy |
| 50-day EMA: | 171.39 | Buy |
| 200-day EMA: | 93.26 | Buy |
KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||